Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 1/2020

01-01-2020 | Lymphoma | Letter to the Editor

Difficult Causality Relationship between Colorectal Cancer and Schistosomiasis

Authors: Tchin Darre, Toukilnan Djiwa, Sassil Dare, Fousseni Alassani, Gado Napo-Koura

Published in: Pathology & Oncology Research | Issue 1/2020

Login to get access

Abstract

The purpose of the study was to determine the nature of the association between colorectal cancer and schistosomiasis infection. This was a retrospective and descriptive study of colorectal cancers and to identify cases associated with schistosomiasis. A total of 814 cases of rectal colorectal cancer were collected and 3 cases were associated with schistosomiasis. These are 2 cases of Liberkunian adenocarcinoma and one case of malt lymphoma. The patients were all farmers and from rural areas. A co-infection with HIV was found in his 3 patients. Our data show an extreme rarity of the association colorectal cancer and schistosomiasis; it seems difficult to conceive of a causal relationship.
Literature
1.
Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S (2016) Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4(9):e609–e616CrossRef
2.
Lapoile E, Bellaiche G, Boucard M et al (2008) Cancer du rectum associé à une infection à Schistosoma hematobium. Gastroenterol Clin Biol 30(10):1225–1226CrossRef
3.
Darré T, Kpatcha K, Tchaou M et al (2015) Histological aspect of urinary schistosomiasis in Togo: results of a cohort of 192 cases. Bull Soc Pathol Exot 108(2):124–125CrossRef
4.
Ferguson AR (1911) Associated bilharziosis and primary malignant disease of the urinary bladder with observations on a series of forty cases. J Pathol Bacteriol 16(1):76–94CrossRef
5.
Gaye AM, Doh K, Thiam I, Bentefouet L, Woto-Gaye G (2016) Schistosomiasis and cancer: a fortuitous association or relationships cause and effect. Bull Cancer 103(9):806–807CrossRef
Metadata
Title
Difficult Causality Relationship between Colorectal Cancer and Schistosomiasis
Authors
Tchin Darre
Toukilnan Djiwa
Sassil Dare
Fousseni Alassani
Gado Napo-Koura
Publication date
01-01-2020
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/2020
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-018-00566-0

Other articles of this Issue 1/2020

Pathology & Oncology Research 1/2020 Go to the issue

Review

Primary Osteosarcoma of the Liver: Case Report and Literature Review

Letter to the Editor

Next-Generation Sequencing Identifies Novel RTK VUSs in Breast Cancer with an Emphasis on ROS1, ERBB4, ALK and NTRK3

Original Article

Precursor Lesions of the Vocal Cord: a Study on the Diagnostic Role of Histomorphology, Histometry and Ki-67 Proliferation

Review

mTOR in Lung Neoplasms

Original Article

The Overexpression of CD80 and ISG15 Are Associated with the Progression and Metastasis of Breast Cancer by a Meta-Analysis Integrating Three Microarray Datasets

Original Article

Association of Combined Tobacco Smoking, Hormonal Contraceptive use and Status Matrimonial with Cervical Cancer Evolution in Tunisian Women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits